Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

Journal of the National Cancer Institute

Volumn 98, Issue 10, 2006, Pages 715-717

  Stephenson, Andrew J ^a   Scardino, Peter T ^a   Eastham, James A ^a   Bianco Jr , Fernando J ^a   Dotan, Zohar A ^a   Fearn, Paul A ^a   Kattan, Michael W ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; CANCER RECURRENCE; COHORT ANALYSIS; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; TREATMENT OUTCOME; VALIDATION STUDY; AGED; BIOPSY; BLOOD; DISEASE COURSE; DISEASE FREE SURVIVAL; IMMUNOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTION AND FORECASTING; PROSTATE TUMOR; RISK FACTOR; TUMOR RECURRENCE;

PROSTATE SPECIFIC ANTIGEN;

AGED; BIOPSY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 33646945083     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj190     Document Type: Article

References (24)

1. Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998;90:766-71.
2. Graefen M, Karakiewicz PI, Cagiannos I, Quinn DI, Henshall SM, Grygiel JJ, et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2002;20: 3206-12.
3. Bianco FJ Jr, Kattan MW, Scardino PT, Powell IJ, Pontes JE, Wood DP Jr. Radical prostatectomy nomograms in black American men: Accuracy and applicability. J Urol 2003; 170:73-6; discussion 76-7.
4. Greene KL, Meng MV, Elkin EP, Cooperberg MR, Pasta DJ, Kattan MW, et al. Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: Results from cancer of the prostate strategic urological research endeavor (capsure). J Urol 2004;171(6 Pt 1):2255-9.
5. Blumberg JW. PDA applications for physicians. ASCO News 2004;16:S4-6.
6. Kattan MW, Zelefsky MJ, Kupelian PA, Scardino PT, Fuks Z, Leibel SA. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol 2000;18:3352-9.
7. Kattan MW, Potters L, Blasko JC, Bayer DC, Fearn P, Cavanagh W, et al. Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. Urology 2001;58:393-9.
8. Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, Diblasio CJ, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2005;23:7005-12.
9. D'Amico AV, Whittington R, Malkowicz SB, Wu YH, Chen MH, Hurwitz M, et al. Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials. J Clin Oncol 2000;18:3240-6.
10. Cagiannos I, Karakiewicz P, Graefen M, Eastham JA, Ohori M, Rabbani F, et al. Is year of radical prostatectomy a predictor of outcome in prostate cancer? J Urol 2004;171(2 Pt 1):692-6.
11. Albertsen PC, Hanley JA, Barrows GH, Penson DF, Kowalczyk PD, Sanders MM, et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 2005;97:1248-53.
12. Bears OH. American Joint Committee on Cancer manual for cancer staging. 4th ed. Philadelphia (PA): Lippincott; 1992.
13. Stephenson AJ, Scardino PT, Eastham JA, Lilja H, Bianco FJ Jr, Dotan ZA, et al. Defining biochemical recurrence of prostate cancer after radical prostatectomy: A proposal for a standardized definition. J Urol 2005;173(4 Suppl):183; abstract 671.
14. Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA 1982;247:2543-6.
15. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York NY: Chapman & Hall; 1993.
16. Eastham JA, Kattan MW, Riedel E, Begg CB, Wheeler TM, Gerigk C, et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol 2003;170(6 Pt 1):2292-5.
17. Swindle P, Eastham JA, Ohori M, Kattan MW, Wheeler T, Maru N, et al. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 2005;174:903-7.
18. Bianco FJ Jr, Scardino PT, Kattan MW, Rhee AC, Eastham JA. Surgeon volume is a predictor of improved outcomes in radical prostatectomy patients. J Urol 2004;171(4 Suppl):211; abstract 796.
19. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999;281: 1591-7.
20. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 2005;294:433-9.
21. Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: Does practice reflect the evidence? JAMA 2003;289:1414-20.
22. Kattan MW, Shariat SF, Andrews B, Zhu K, Canto E, Matsumoto K, et al. The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer. J Clin Oncol 2003;21:3573-9.
23. Kattan MW. Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst 2003;95:634-5.
24. Kattan MW, Eastham JA, Wheeler TM, Maru N, Scardino PT, Erbersdobler A, et al. Counseling men with prostate cancer: A nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol 2003;170:1792-7.